Novel protein, C2orf15-MRPL30-novel lincRNA readthrough (ENSG00000241962)

This locus represents a readthrough transcript between the adjacent *C2orf15* and *MRPL30* genes, incorporating features of both coding and non-coding regions with a presumed long intergenic non-coding RNA segment. There is no substantial protein or molecular function characterized, and it is not recognized as a relevant therapeutic target or biomarker. Such readthrough events are often identified in genome annotation projects but generally lack evidence for translation into functional proteins or roles in disease[3]. The entry "novel protein, C2orf15-MRPL30-novel lincRNA readthrough" (ENSG00000241962) refers to a readthrough transcript combining *C2orf15*, *MRPL30*, and a novel long intergenic non-coding RNA (lincRNA)[3]. This entity is catalogued as a protein-coding gene but lacks substantial experimental characterization, including protein product evidence and functional annotation. There is no evidence that this gene product is a characterized or druggable therapeutic target, such as a receptor, enzyme, transporter, or similar[3]. This entry does not correspond to a well-defined protein or therapeutic target. It likely represents a *readthrough*, which is a non-canonical transcriptional event that fuses exons from adjacent loci, often resulting in low or uncharacterized expression. There is insufficient evidence for its biological relevance as a molecular target[3]. The entry is best categorized as an uncharacterized, putative readthrough gene with unknown function. There is no literature evidence or database classification indicating a defined protein, receptor, enzyme, or drug target function for ENSG00000241962. No alias or synonym mapping it to a known therapeutic or biological target was found. If you are seeking structured information about therapeutic receptors, enzymes, or drug targets, this gene does not currently qualify based on available annotation and characterization[3].

Other names

C2orf15-MRPL30 readthroughENSG00000241962